Successful ECMO therapy in a child with COVID-19-associated ARDS and acute lymphoblastic leukemia
- PMID: 34022118
- PMCID: PMC8209893
- DOI: 10.1002/pbc.29100
Successful ECMO therapy in a child with COVID-19-associated ARDS and acute lymphoblastic leukemia
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Comment on
-
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021. JAMA. 2020. PMID: 32876695 Free PMC article. Clinical Trial.
References
-
- Escherich G, zur Stadt U, Zimmermann M, Horstmann MA. Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08–09 trial. Br J Haematol. 2013;163(2):240‐247. - PubMed
-
- Ankermann T, von BernuthH, Hübner J, et al. Medikamentöse Behandlung von Kindern mit COVID‐19: Stellungnahme der DGPI, GPP, API, GKJR und STAKOB zur medikamentösen Behandlung von Kindern mit COVID‐19. 2020. https://dgpi.de/stellungnahme-medikamentoese-behandlung-von-kindern-mit-.... Accessed November 26, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical